Effect of Ipratropium Bromide and Tiotropium Bromide in Patients Suffers From Chronic Obstructive Pulmonary Disease (COPD), Attending in Tertiary Care Hospital, at S.K.M.C.H., Muzaffarpur

Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 9

Abstract

Objective: The aim of present study was to compare the effect of 9 months treatment with inhaled Ipratropium bromide and inhaled Tiotropium bromide on airflow obstruction and symptoms, by assessing clinical improvement as well as alteration on pulmonary function tests in cases of mild to moderate chronic obstructive pulmonary disease (COPD). Material and Methods: A total of 64 patients of 25-65 year of age group of either sex suffered from mild to moderate chronic obstructive pulmonary Disease (COPD) diagnosed by clinical examination, Pulmonary function tests (FEV1, FEV1/FVC, PEFR, FVC by spirometry) and Routine investigation (CBC, Blood sugar, LFT, KFT, Arterial Blood gas analysis, X-ray chest and ECG) were included in the study. All the patient were randomized into two treatment group, with equal proportion of patients (Group A-32 patients and Group- B 32 patients) on the basis of age, sex, severity of disease and smoking habits. Group A patients received inhalation of Ipratropium bromide 40 micrograms by 6 hourly daily for 9 months and the group B patients received inhalation of Tiotropium bromide 18 micrograms by once daily for 9 months. All the patients were followed up at 1 month, 3 months, 6 month and 9 months interval to monitor and improvements in clinical status, Pulmonary function tests, frequency of acute exacerbation and need of additional drugs. Any adverse effect of drugs and any changes in laboratory parameter were noted. Results: Inhaled Tiotropium bromide was more effective in compare to Ipratropium bromide in patients with mild to moderate cases of COPD And Both drugs were equally effective in clinical improvements over the period of a months. Conclusion: It is suggested that Tiotropium bromide (18 micrograms OD) inhalation could be more suitable and acceptable by the patients of COPD due to its longer duration of action and it is more effectiveness as compared to Ipratropium bromide (40 micrograms QID inhalation).

Authors and Affiliations

Dr Deepak Kumar

Keywords

Related Articles

Histopathological Spectrum of Lesions in Orchidectomy Specimens – A Clinicopathological Study in Tertiary Care Hospital

Background: Testicular Lesions are common in males of all age groups. The lesions range from Benign to malignant. The treatment is different for different histologic subtypes. Objective: The aim of this study is to study...

Evaluation of Serum Autotaxin as a Novel Noninvasive Marker for Assessment of Hepatic Fibrosis in Chronic Hepatitis C Patients

Egypt has a high prevalence of HCV infection which causes hepatic fibrosis. Assessment of the degree of hepatic fibrosis is essential for decision of antiviral therapy. Untill now, liver biopsy is the gold standard for a...

Genexpert® MTB/RIF for Rapid Identification of Clinically Suspected MDR-TB Cases

Introduction: An alarming increase in global incidence of drug-resistant Mycobacterium tuberculosis infection has created a critical need for methods that can rapidly detect it. Multidrug-resistant tuberculosis is define...

Effect of Throwers Ten Program on Performance in Fast Bowlers “Randomized Control Trail”

Background: Fast bowlers are considered some of the most influential players on the cricket field. Bowling in cricket involves an initial run-up, numerous rotations and circumduction of a straight arm about the glenohume...

Conjunctival Rhinosporidiosis: Basket of Sporangia Hidden Below the Puncta

Rhinosporidiosis is an infection caused by Rhinosporidium seeberi. R. seeberi has recently been classified as a Mesomycetozoea, an aquatic protozoan parasite .we report a rare case of 45 year old male with conjunctival m...

Download PDF file
  • EP ID EP516999
  • DOI -
  • Views 42
  • Downloads 0

How To Cite

Dr Deepak Kumar (2018). Effect of Ipratropium Bromide and Tiotropium Bromide in Patients Suffers From Chronic Obstructive Pulmonary Disease (COPD), Attending in Tertiary Care Hospital, at S.K.M.C.H., Muzaffarpur. Journal of Medical Science And clinical Research, 6(9), 1101-1104. https://europub.co.uk/articles/-A-516999